Macroaxis: Personalized Investing

Personalized Investing and

Digital Wealth Optimization

GILD AMGN CELG BIIB 
Benchmark  United States  NYSE  10,788   71.013 Index Moved Down -0.65%  


Processing
Collecting data for STEM

StemCells Inc StemCells Inc

   
$1.05
Change

0.01

0.96%

Year To Date
0.842.43
Last 1 Month(s)
0.871.14
Trading Day 
1.021.06
5 Days Price Trend
January 25, 2015 
Highest Price  
Lowest Price  
January 8, 2015 
December 23, 2014 

StemCells Market Sensitivity

SymbolSTEM
ISINUS085857R200
CUSIP085857R20
NameStemCells Inc
InstrumentUSA Stock
SectorHealthcare
IndustryBiotechnology
BenchmarkNYSE
Webhttp://www.stemcellsinc.com
Contact Number510. 456. 4000
CurrencyUSD - US Dollar
ExchangeTraded on Nasdaq Capital Markets
 

StemCells key fundamentals

Current Valuation55.27 M
Shares Outstanding68.73 M
Number of Shares Shorted2.75 M
Revenue1.16 M

StemCells agains markets

 thisGreen STEM STEM agains markets  0.96 % Macroaxis: 0.96 Moved Up  
 
 United States Nasdaq   0.16 % Macroaxis: 0.16 Moved Up  
 
 United States Russel   0.12 % Macroaxis: 0.12 Moved Down  
 
 United States SP 500   0.55 % Macroaxis: 0.55 Moved Down  
 
 United States NYSE   0.65 % Macroaxis: 0.65 Moved Down  
 
Compare to Competition   Compare Correlations

StemCells Leadership

Martin McGlynn CEO and President Director, Member of Strategic Transactions Committee, CEO of StemCells California Inc and President of StemCells California Inc
John Schwartz Independent Chairman of the Board, Ph.D

StemCells Diversification Suggestion

Use StemCells to enhance returns of your portfolios. The stock experiences moderate upward volatility. Check odds of StemCells to be traded at $1.155 in 30 days

StemCells Price and Market Media

The median price of StemCells for the period between Fri, Dec 26, 2014 and Sun, Jan 25, 2015 is 1.04 with a coefficient of variation of 7.3. The daily time series for the period is distributed with a sample standard deviation of 0.07, arithmetic mean of 1.02, and mean deviation of 0.06. The Stock did not receive any noticable media coverage during the period.
StemCells Value
 
Change Benchmark  Embed   Timeline 

StemCells Summary

StemCells Inc [STEM] is traded on Nasdaq Capital Markets in USA. It is located in Newark, CA and employs 58 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 72.85 M. StemCells Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 68.73 M outstanding shares of which 2.75 M shares are at this time shorted by private and institutional investors with about 3.6 trading days to cover.
StemCells, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of stem cell therapeutics, and related tools and technologies for stem cellbased research and drug discovery and development. more
Over 30
Days
10
Out Of
100
 
More
Than
94
%
 

StemCells Alerts

StemCells Inc has some characteristics of a very speculative penny stock
StemCells Inc appears to be very risky and stock price may revert if volatility continues
StemCells Inc has high likelihood to experience some financial distress in the next 2 years
The company reported previous year revenue of 1.16 M. Net Loss for the year was (29.46 M) with profit before overhead, payroll, taxes, and interest of 886.64 K.
STEMCELLS INC currently holds about 32.21 M in cash with (27.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47.
Roughly 24.0% of the company outstanding shares are owned by corporate insiders

StemCells Earnings Estimates

StemCells Inc normalized analysts earnings estimates over time
  

StemCells Research Report

Get StemCells research report. Reports are available in pdf format. Click Generate StemCells report to view
  

StemCells Pair Trading Analysis

Correlation analysis and pair trading evaluation for StemCells and Gilead Sciences
  

Explore Investment Opportunities

Investing ideals could easily outperform a given market if properly optimized

StemCells Directors

Irving Weissman Director
Eric Bjerkholt Independent Director
R Greer Independent Director
Ricardo Levy Independent Director
Alan Trounson Director

StemCells Fundamentals

Shares Outstanding vs Beta
Return On Asset vs One Year High
Shares Outstanding vs Earnings Per Share

StemCells vs Competition

StemCells vs. Gilead Sciences Inc
StemCells vs. Amgen Inc
StemCells vs. Celgene Corporation
StemCells vs. Biogen Idec Inc
StemCells vs. Regeneron Pharmaceuticals Inc
StemCells vs. Alexion Pharmaceuticals Inc
StemCells vs. Vertex Pharmaceuticals Incorporated
StemCells vs. Illumina Inc
StemCells vs. BioMarin Pharmaceutical Inc
StemCells vs. Incyte Corporation

StemCells January 25, 2015 Opportunity Range

Information Ratio0.1301
Maximum Drawdown14.84
Value At Risk(5.26)

 

Analytics

Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 

Research Modules

Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 

Services And Technology

Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 

Free Investor Tools

World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 

About Us

About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities